PTAB Invalidates Most Of Pfizer Pneumonia Vaccine Patent
Following a challenge from Merck Sharp & Dohme Corp., the Patent Trial and Appeal Board said Friday that all but one claim in a patent related to Pfizer Inc.'s top-selling Prevnar...To view the full article, register now.
Already a subscriber? Click here to view full article